Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rebuffing Roche's Offer, Illumina Points to Growing Clinical Adoption of its Sequencing Platforms
April 04, 2012
Rebuffing Roche's Offer, Illumina Points to Growing Clinical Adoption of its Sequencing Platforms
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
Illumina Plans MiSeq Disease Panels, CLIA RapidTrack Whole-Genome Sequencing Service
July 25, 2012 / Clinical Sequencing News
Illumina Sees Growing Commercial Customer Base; Doubled Clinical HiSeq Placements in 2011
February 8, 2012 / Clinical Sequencing News
Illumina to Apply Rare-Cell Capture to Ovarian Cancer Program; Expects Clinical Apps for MiSeq
May 4, 2011 / Clinical Sequencing News
Illumina's Low-Cost MiSeq Promises to Speed up Next-Gen Sequencing
January 18, 2011 / In Sequence